The Journal for ImmunoTherapy of CancerĀ (JITC) is an open access, peer-reviewed journal that aims to enrich communication and advance scientific understanding in the rapidly evolving fields of tumor immunology and cancer immunotherapy. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
- Publisher
- BMJ
- Website
- https://jitc.bmj.com/
Some content from Wikipedia,
licensed under CC BY-SA